Q-Line Biotech logo

Q-Line Biotech IPO Review

Q-Line Biotech IPO Pages

πŸ“

Detailed review coming soon

Our editorial team is preparing an in-depth analysis of Q-Line Biotech IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.

Price / Issue Price
β‚Ή343
Lot Size
400
Type
Sme
Exchange
BSE SME
Sector
Healthcare & Pharma
View official prospectus β†’
Already listed. Issued at β‚Ή343, listed at β‚Ή452 (+31.78%) on 28 May 2026.